Literature DB >> 7737038

A carbamate insecticide: a case study of aldicarb.

R L Baron1.   

Abstract

Aldicarb, the active ingredient in the insecticide TEMIK, was introduced to the agricultural community over 25 years ago. It has been registered worldwide to control a wide variety of insect, mite, and nematode pests in agriculture. The toxicological research database supporting the registration and use of aldicarb was generated over more than 25 years and contains more than 280 animal studies on 12 species of animals, 2 clinical human trials, and over 20 human monitoring studies. This database, which includes biochemical aspects (metabolism and mode-of-action studies), acute toxicity and special short-term toxicity studies, long-term toxicity studies, and epidemiological observations in humans, serves as the starting point for the evaluation of the risks associated with the acceptance of levels of aldicarb residues in food and drinking water and for the more direct occupational exposure. This article highlights the available toxicological data and reviews worldwide regulation of aldicarb. Included in these discussions is a brief description of the toxicological end point upon which regulatory decisions have been based, namely acetylcholinesterase depression. Aldicarb, the N-methylcarbamic acid ester of 2-methyl-2-(methylthio) propionaldehyde oxime, was the first of a limited group of insecticidal oxime N-methylcarbamates that have properties distinct from N-methylcarbamates which have a phenolic constituent, instead of the oxime moiety. Aldicarb is highly water-soluble (approximately 6000 ppm), nonvolatile, relatively stable under acidic conditions, and is easily degraded under alkaline conditions. These properties are important determinants of its systemic action in plants and of its problematic environmental behavior. Possible environmental hazards involving the chemical include groundwater contamination and (more recently) excessive terminal residues in certain foods.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7737038      PMCID: PMC1566767          DOI: 10.1289/ehp.94102s1123

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  3 in total

Review 1.  Toxicology of aldicarb.

Authors:  R L Baron; T L Merriam
Journal:  Rev Environ Contam Toxicol       Date:  1988       Impact factor: 7.563

2.  Effect of the insecticidal carbamate derivatives (carbofuran, pirimicarb, aldicarb) on the activity of acetylcholinesterase in tissues from pregnant rats and fetuses.

Authors:  C Cambon; C Declume; R Derache
Journal:  Toxicol Appl Pharmacol       Date:  1979-06-30       Impact factor: 4.219

3.  Foetal and maternal rat brain acetylcholinesterase: isoenzymes changes following insecticidal carbamate derivatives poisoning.

Authors:  C Cambon; C Declume; R Derache
Journal:  Arch Toxicol       Date:  1980-10       Impact factor: 5.153

  3 in total
  4 in total

1.  Aldicarb-related suicide attempt cases in North of France (2012-2021).

Authors:  Marie Lenski; Agnès Letrillart; Alexandr Gish; Patrick Nisse; Jean-Michel Gaulier; Delphine Allorge
Journal:  Toxicol Res (Camb)       Date:  2022-05-31       Impact factor: 2.680

Review 2.  Parasite neuropeptide biology: Seeding rational drug target selection?

Authors:  Paul McVeigh; Louise Atkinson; Nikki J Marks; Angela Mousley; Johnathan J Dalzell; Ann Sluder; Lance Hammerland; Aaron G Maule
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-15       Impact factor: 4.077

3.  Exposure to acetylcholinesterase inhibitors alters the physiology and motor function of honeybees.

Authors:  Sally M Williamson; Christopher Moffat; Martha A E Gomersall; Nastja Saranzewa; Christopher N Connolly; Geraldine A Wright
Journal:  Front Physiol       Date:  2013-02-05       Impact factor: 4.566

4.  Intentional Carbofuran poisoning in 7 dogs.

Authors:  Dalma Pivariu; Adrian-Nechita Oros; Flaviu Tabaran; Adrian Gal; Cristian Martonos; Andras-Laszlo Nagy
Journal:  BMC Vet Res       Date:  2020-08-31       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.